Peptide receptor radionuclide therapy induced carcinoid crisis: A case report

Peptide receptor radionuclide therapy (PRRT) is a therapeutic option in inoperable or metastatic neuroendocrine tumours (NETs). PRRT proved to be promising in prolonging survival and delaying disease progression in patients with advanced bronchopulmonary carcinoid. However, it may lead to worsening...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medical journal of Malaysia 2022-01, Vol.77 (1), p.128-131
Hauptverfasser:	Siow Ping, L, Azraai, B N, Subashini, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoid Tumor - drug therapy Humans Male Middle Aged Neuroendocrine Tumors - drug therapy Neuroendocrine Tumors - pathology Octreotide - therapeutic use Radioisotopes - therapeutic use Receptors, Peptide
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!